Dickens Otieno Onyango1, Courtney M Yuen2, Enos Masini3, Martien Willem Borgdorff4. 1. Kisumu County Department of Health, Kisumu, Kenya. Electronic address: macdickens2002@gmail.com. 2. Harvard Medical School, Boston, MA. 3. National Tuberculosis Control Program, Nairobi, Kenya. 4. University of Amsterdam, Amsterdam, Netherlands.
Abstract
OBJECTIVES: To describe the epidemiology of childhood tuberculosis (TB) in Kenya, assess the magnitude of TB/human immunodeficiency virus (HIV) co-infection and identify risk factors for mortality during TB treatment. STUDY DESIGN: We conducted a retrospective analysis of the Kenyan national TB program data for patients enrolled from 2013 through 2015. A total of 23 753 children aged less than 15 years were included in the analysis. Survival analysis was performed with censorship at 9 months and mortality was the main outcome. We used Cox proportional hazards regression for assessing risk factors for mortality. RESULTS: Childhood TB accounted for 9% (n = 24 216) of all patients with TB; 98% of the notified children (n = 23 753) were included in the analysis. TB/HIV co-infection was 28% (n = 6112). Most TB cases (71%; n = 16 969) were detected through self-referral. Treatment was successful in 90% (n = 19 088) and 4% (n = 1058) died. Independent risk factors for mortality included being HIV infected but not on antiretroviral therapy (adjusted hazard ratio [aHR], 4.84; 95% CI, 3.59-6.51), being HIV infected and on antiretroviral therapy (aHR, 3.69; 95% CI, 3.14-4.35), children aged less than 5 years (aHR, 1.25; 95% CI, 1.08-1.44), and being diagnosed with smear negative pulmonary disease (aHR, 1.68; 95% CI, 1.27-2.24). CONCLUSIONS: Most childhood TB cases in Kenya were detected through passive case finding. TB/HIV co-infection is high among children on treatment for TB, and HIV is associated with an increased risk of death. There is a need to intensify active case finding among children. TB prevention interventions among HIV-infected children, early diagnosis of HIV, and early antiretroviral therapy initiation among children on TB treatment should be strengthened.
OBJECTIVES: To describe the epidemiology of childhood tuberculosis (TB) in Kenya, assess the magnitude of TB/human immunodeficiency virus (HIV) co-infection and identify risk factors for mortality during TB treatment. STUDY DESIGN: We conducted a retrospective analysis of the Kenyan national TB program data for patients enrolled from 2013 through 2015. A total of 23 753 children aged less than 15 years were included in the analysis. Survival analysis was performed with censorship at 9 months and mortality was the main outcome. We used Cox proportional hazards regression for assessing risk factors for mortality. RESULTS: Childhood TB accounted for 9% (n = 24 216) of all patients with TB; 98% of the notified children (n = 23 753) were included in the analysis. TB/HIV co-infection was 28% (n = 6112). Most TB cases (71%; n = 16 969) were detected through self-referral. Treatment was successful in 90% (n = 19 088) and 4% (n = 1058) died. Independent risk factors for mortality included being HIV infected but not on antiretroviral therapy (adjusted hazard ratio [aHR], 4.84; 95% CI, 3.59-6.51), being HIV infected and on antiretroviral therapy (aHR, 3.69; 95% CI, 3.14-4.35), children aged less than 5 years (aHR, 1.25; 95% CI, 1.08-1.44), and being diagnosed with smear negative pulmonary disease (aHR, 1.68; 95% CI, 1.27-2.24). CONCLUSIONS: Most childhood TB cases in Kenya were detected through passive case finding. TB/HIV co-infection is high among children on treatment for TB, and HIV is associated with an increased risk of death. There is a need to intensify active case finding among children. TB prevention interventions among HIV-infectedchildren, early diagnosis of HIV, and early antiretroviral therapy initiation among children on TB treatment should be strengthened.
Authors: Francis Hamaimbo Nanzaluka; Sylvia Chibuye; Clara Chola Kasapo; Nelia Langa; Sulani Nyimbili; Given Moonga; Nathan Kapata; Ramya Kumar; Gershom Chongwe Journal: Pan Afr Med J Date: 2019-04-08
Authors: Moses M Ngari; Susanne Schmitz; Christopher Maronga; Lazarus K Mramba; Michel Vaillant Journal: BMC Med Res Methodol Date: 2021-04-27 Impact factor: 4.615
Authors: Dickens Otieno Onyango; Marianne A B van der Sande; Courtney M Yuen; Jerphason Mecha; Daniel Matemo; Elizabeth Oele; John Kinuthia; Grace John-Stewart; Sylvia M LaCourse Journal: J Int AIDS Soc Date: 2022-08 Impact factor: 6.707
Authors: Muhammad Osman; Karen du Preez; James A Seddon; Mareli M Claassens; Rory Dunbar; Sicelo S Dlamini; Alex Welte; Pren Naidoo; Anneke C Hesseling Journal: Pediatrics Date: 2021-03-10 Impact factor: 7.124
Authors: Rodrick R Kisenge; Chris A Rees; Jacqueline M Lauer; Enju Liu; Wafaie W Fawzi; Karim P Manji; Christopher P Duggan Journal: Trop Med Health Date: 2020-06-04
Authors: Alexander W Kay; Helena Rabie; Elizabeth Maleche-Obimbo; Moorine Penninah Sekadde; Mark F Cotton; Anna M Mandalakas Journal: Pathogens Date: 2021-12-29